Smart pre-surgical tumor testing catches germline implications before procedures that would differ dramatically with hereditary syndrome knowledge
Tumor testing and presurgical germline implications connect molecular findings in a patient’s tumor with inherited cancer risk that may affect the operation itself, not merely later drug selection. Immunohistochemistry, microsatellite-instability testing, and tumor sequencing can identify signals associated with Lynch syndrome, BRCA1/2-related cancer, hereditary diffuse gastric cancer, or other syndromes.…